Skip to main content
Molecure S.A. logo

Molecure S.A. — Investor Relations & Filings

Ticker · MOC ISIN · PLONCTH00011 LEI · 2594003L11V38ZCVKZ09 WAR Professional, scientific and technical activities
Open in API
Filings indexed 194 across all filing types
Latest filing 2026-06-02 Remuneration Information
Country PL Poland
Listing WAR MOC

About Molecure S.A.

https://molecure.com/

Molecure S.A. is a clinical-stage biotechnology company focused on discovering and developing first-in-class small molecule drugs for diseases with high unmet medical needs. The company utilizes its expertise in medicinal chemistry and biology to identify, validate, and modulate novel protein and mRNA targets. Its therapeutic pipeline is concentrated on oncological, inflammatory, and fibrotic diseases. Molecure operates a proprietary discovery platform for targeting mRNA with small molecules, enabling the development of innovative therapies for previously untreatable conditions.

Recent filings

Filing Released Lang Actions
sprawozdanie o wynagrodzeniach RN i Zarządu za 2025 r.
Remuneration Information Classification · 92% confidence The document is a detailed annual report on the remuneration of the Management Board and Supervisory Board for 2025, including compensation components, amounts paid, non-cash benefits, stock awards, and compliance with the company’s remuneration policy per legal requirements. This falls squarely under Remuneration Information (report detailing compensation for top executives and directors).
2026-06-02 Polish
projekty uchwał na ZWZ
AGM Information Classification · 90% confidence The document is titled “Projekty uchwał na Zwyczajne Walne Zgromadzenie” and contains draft resolutions (agenda items, approval of financial statements, discharge of management, etc.) to be voted at the Ordinary General Meeting of Molecure S.A. This is pre‐meetings materials for an AGM, fitting the definition of AGM Information (AGM-R).
2026-06-02 Polish
wzór pełnomocnictwa na ZWZ
Proxy Solicitation & Information Statement Classification · 92% confidence The document is a template power-of-attorney (proxy) form and detailed voting instruction sent to shareholders ahead of the Ordinary General Meeting (AGM) of Molecure S.A., including agenda items and proposed resolutions for which shareholders must provide voting directions. This matches the definition of a Proxy Solicitation & Information Statement, not an AGM presentation or the voting results. Therefore, the appropriate classification is PSI.
2026-06-02 Polish
sprawozdanie Rady Nadzorczej za 2025 r.
Governance Information Classification · 87% confidence The document is the Supervisory Board’s report under Polish law (art. 382 KSH) to be submitted at the Ordinary General Meeting, detailing board composition, committee structure, independence, internal controls, and governance practices, as well as its evaluation of the Management Board’s activity and the annual financial statements. It is not a full Annual Report (10-K) or an earnings release, nor a proxy statement or announcement of report availability. It primarily focuses on governance, board oversight, and corporate governance practices, fitting the Governance Information category.
2026-06-02 Polish
opinia biegłego o sprawozdaniu o wynagrodzeniach
Audit Report / Information Classification · 83% confidence The document is an independent auditor’s attestation report from UHY ECA Audyt concerning the completeness of the company’s remuneration report under Polish public offering regulations. It is not an Annual Report, earnings release, management discussion, or meeting materials; rather it is a standalone audit assurance report. According to the filing definitions, standalone audit reports fall under Audit Report / Information (AR).
2026-06-02 Polish
Projekty uchwał Zwyczajnego Walnego Zgromadzenia - Content (PL)
AGM Information Classification · 87% confidence The document is a notice from the Management Board of MOLECURE S.A. transmitting the draft resolutions, Supervisory Board’s activity report and remuneration report (with auditor’s opinion) for consideration at the Ordinary General Meeting to be held on June 29, 2026. It is distributing AGM materials rather than presenting standalone financial statements, earnings highlights or a proxy solicitation per se. Under the filing definitions, this falls squarely under AGM Information (materials shared for an Annual/Ordinary General Meeting).
2026-06-02 Polish

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.